Evidence map›Paper›PMID 32719556›Full record

ArticleNature chemical biology2020

p63 uses a switch-like mechanism to set the threshold for induction of apoptosis.

Jakob Gebel, Marcel Tuppi, Apirat Chaikuad, Katharina Hötte, Martin Schröder, Laura Schulz, Frank Löhr, Niklas Gutfreund, Franziska Finke, Erik Henrich and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Fuzziness in enzymatic catalysis.Current opinion in structural biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein kinase 1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Jakob Gebel *Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-8994-9153
Marcel Tuppi *Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany. marcel.tuppi@crick.ac.uk.ORCID http://orcid.org/0000-0002-2963-5902
Apirat Chaikuad *Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0003-1120-2209
Katharina HöttePhysikalische Biologie, Buchmann Institute for Molecular Life Sciences (BMLS), Goethe University, Frankfurt am Main, Germany.
Martin SchröderInstitute of Pharmaceutical Chemistry, Goethe University, Frankfurt am Main, Germany.
Laura SchulzDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-2403-7129
Frank LöhrInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.
Niklas GutfreundInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.
Franziska FinkeInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.
Erik HenrichInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.
Julija MezhyrovaInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany.
Ralf LehnertMathezentrum, Goethe University, Frankfurt am Main, Germany.
Francesco PampaloniPhysikalische Biologie, Buchmann Institute for Molecular Life Sciences (BMLS), Goethe University, Frankfurt am Main, Germany.
Gerhard HummerDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-7768-746X
Ernst H K StelzerPhysikalische Biologie, Buchmann Institute for Molecular Life Sciences (BMLS), Goethe University, Frankfurt am Main, Germany.
Stefan KnappInstitute of Pharmaceutical Chemistry, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-5995-6494
Volker DötschInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main, Germany. vdoetsch@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0001-5720-212X
Goethe University Frankfurt · DEMax Planck Institute of Biophysics · DE

Funding

CIHRWellcome Trust
6 · The paper itself

Abstract

The p53 homolog TAp63α is the transcriptional key regulator of genome integrity in oocytes. After DNA damage, TAp63α is activated by multistep phosphorylation involving multiple phosphorylation events by the kinase CK1, which triggers the transition from a dimeric and inactive conformation to an open and active tetramer that initiates apoptosis. By measuring activation kinetics in ovaries and single-site phosphorylation kinetics in vitro with peptides and full-length protein, we show that TAp63α phosphorylation follows a biphasic behavior. Although the first two CK1 phosphorylation events are fast, the third one, which constitutes the decisive step to form the active conformation, is slow. Structure determination of CK1 in complex with differently phosphorylated peptides reveals the structural mechanism for the difference in the kinetic behavior based on an unusual CK1/TAp63α substrate interaction in which the product of one phosphorylation step acts as an inhibitor for the following one.

Indexed as

AnimalsApoptosisCatalytic DomainDNA DamageFemaleHumansMiceModels, MolecularMolecular Dynamics SimulationOocytesPhosphorylationProtein ConformationTime FactorsTranscription FactorsTumor Suppressor ProteinsTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID32719556
OpenAlexW3045003856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.